STAT

APRIL 12, 2024

The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a dairy worker contracting the virus , demands a departure from the usual reassurances offered by federal health officials. While they emphasize there’s no cause for alarm and assert diligent monitoring, it’s imperative we break from this familiar script. H5N1, a strain of the flu virus known to infect bird species globally and several mammalian species in the U.S. since 2022, has now appeared to have bre

364

364

ALiEM - Pharm Pearls

APRIL 12, 2024

Traditionally large-bore tube thoracostomy has been the standard of care for treating many acute intrathoracic pathologies [1]. However, the advent of less invasive small-bore chest tubes, also known as pigtail catheters, has gradually led to a paradigm shift. Pigtails provide a less invasive and often better tolerated alternative to traditional chest tubes and allow for adequate treatment of pneumothoraces and uncomplicated pleural effusions [1-5].

Inpatient 177

Inpatient 177

STAT

APRIL 12, 2024

In the final year of World War II, Nazi troops starved the Netherlands in a brutal event known as the Dutch Hunger Winter. Some 20,000 people died and millions more suffered from this man-made famine. The survivors went on to have children and even grandchildren with increased rates of metabolic issues like diabetes, hypertension, and schizophrenia.

Diabetes 359

Diabetes 359

PharmaVoice

APRIL 12, 2024

Why these clinical setbacks impacted the companies, industry and patients.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 12, 2024

LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions.   The announcement from the European Medicines Agency echoes the findings of a review by the U.S. Food and Drug Administration, which in January said it did not find a causal relationship between the class of weight loss and diabetes medications and suicidal ideation.

Diabetes 356

Diabetes 356

The Pharmacist

APRIL 12, 2024

Most community pharmacies in England now running the Pharmacy First service which enables them to diagnose and treat seven specific conditions. Under the service, pharmacists can prescribe set medications where appropriate, without recourse to a GP. This will hopefully reduce some of the current pressures on general practice. This series of guides assumes that pharmacists […] The post Pharmacy First: Top tips for managing non-bullous impetigo appeared first on The Pharmacist.

Community Pharmacies 124

Community Pharmacies Vaccines 124

PharmaTech

APRIL 12, 2024

The agency’s risk assessment committee has concluded that available evidence has not been found that supports a causal association between glucagon-like peptide-1 receptor agonists and self-harming thoughts and actions.

Diabetes 119

Diabetes 119

STAT

APRIL 12, 2024

Powerful groups of mostly men are making major decisions about biology and bodies they know little about. Embryos in deep freeze that may never be used are just the latest example. As a professor of biomedical design for the past 20 years, I have seen this trend increase in a seemingly exponential way since the Supreme Court’s Dobbs decision overturned Roe v.

317

317

pharmaphorum

APRIL 12, 2024

Uncover the importance of adaptive EDI strategies in the UK through research and discussions on diversity. Explore the benefits and best practices in promoting a more inclusive workplace.

117

117

STAT

APRIL 12, 2024

In response to controversy, a group of Colorado lawmakers is abandoning a bill that would have required a new state board — which is chartered with setting caps for the cost of medicines — to create exemptions for rare disease drugs. Instead, the lawmakers introduced a watered-down version to require the Prescription Drug Affordability Board to consider different uses of any medicine with a so-called orphan designation, which refers to treatments for rare diseases.

Drug Pricing 312

Drug Pricing 312

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

APRIL 12, 2024

Stay up to date on the latest agency, consultancy, and investor hires from March 2024 with Changing Faces. Learn about Langland, 4BIO Capital, Jeito Capital and more.

119

119

STAT

APRIL 12, 2024

If a preventable error that might cause harm occurs during medical care, should there be transparency, or should the incident be swept under the rug? A rule proposed by the U.S. Nuclear Regulatory Commission (NRC) leans toward the latter. We believe that transparency is best: patients need it so they know what happens to them during their care; clinicians need it so they can mitigate harm and prevent future errors.

285

285

Pharma Times

APRIL 12, 2024

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases

154

154

STAT

APRIL 12, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with what is my final edition of The Readout on my last day at STAT. I’ve had a wonderful time covering biotech here these last eight years, and that’s in no small part a testament to the clever and engaged readers of this very newsletter.

Drug Pricing 284

Drug Pricing Drug Development Vaccines 284

The Pharmacist

APRIL 12, 2024

The number of phone calls to pharmacies more than tripled between February and March 2020, while home deliveries of medication to vulnerable patients more than doubled, the UK Covid-19 Inquiry heard this week. Speaking on behalf of the National Pharmacy Association (NPA) at the inquiry hearing this week, legal representative Deirdre Domingo, said members had […] The post Calls to pharmacies tripled during pandemic, inquiry told appeared first on The Pharmacist.

111

111

STAT

APRIL 12, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch up on our reading and napping, promenade with the official mascots and hold another listening party with Mrs. Pharmalot, and the rotation will likely include this , this , this , this , and this.

Drug Development 260

Drug Development Diabetes Drug Pricing 260

pharmaphorum

APRIL 12, 2024

To mark World Parkinson’s Day, former broadcaster Jeremy Paxman has delivered a list of recommendations for improving how the disease is managed in the UK to Prime Minister Rishi Sunak.

105

105

STAT

APRIL 12, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

254

254

pharmaphorum

APRIL 12, 2024

BioMarin’s Voxzogo has been shown to increase growth rates in children with hypochondroplasia, a genetic cause of very short stature, in a phase 2 trial

111

111

pharmacy mentor

APRIL 12, 2024

With the Pharmacy First (PF) program rolling out in the UK, pharmacists have a great new opportunity to engage with their community and offer treatments for a range of common ailments. This makes care more convenient for patients and eases the burdens on traditional healthcare facilities. Many pharmacists are also looking at Pharmacy First as an opportunity to increase revenue.

Vaccines 98

Vaccines 98

pharmaphorum

APRIL 12, 2024

Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.

110

110

The Pharmacist

APRIL 12, 2024

Brothers Chris and Jonathan Lo, of Lo's Pharmacy Group, speak about why they chose a hub and spoke approach and the impact it has had on their business Lo’s Pharmacy Group, based in South Yorkshire, introduced a hub and spoke model of dispensing for their original pack repeat prescriptions over a year ago. Since then, […] The post 'We're scaling up hub and spoke in our independent pharmacy group' appeared first on The Pharmacist.

Independent Pharmacies 97

Independent Pharmacies 97

Pharma Times

APRIL 12, 2024

Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions

111

111

European Pharmaceutical Review

APRIL 12, 2024

There has been a “notable” rise in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology for gene therapies over the past five years, according to data and analytics firm GlobalData. These agreements have amassed a total deal value of $21 billion. Of note, between 2020 to 2022, there was a “remarkable surge” in deal worth.

91

91

pharmaphorum

APRIL 12, 2024

Shareholders in AstraZeneca have voted to approve controversial increase in the salary and bonus package for CEO Pascal Soriot.

Packaging 104

Packaging 104

Drug Channels

APRIL 12, 2024

Today’s guest post comes from Jessica Lens, Chief Patient Experience Officer at CareMetx. Jessica discusses the challenges of patient nonadherence. She then outlines how manufacturers can build adherence into their patient services program to increase patient engagement. To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence.

84

84

European Pharmaceutical Review

APRIL 12, 2024

The first-of-its-kind global Phase II study for vosoritide has demonstrated that children with hypochondroplasia, a genetic cause of short stature in children, achieved an increased average growth rate of 1.8 cm annually. [vosoritide] is the first medicine that has been developed to specifically target the pathway involved in hypochondroplasia” “This is the first medicine that has been developed to specifically target the pathway involved in hypochondroplasia,” commented Dr Andrew Dauber,

Hospitals 82

Hospitals 82

Outsourcing Pharma

APRIL 12, 2024

Yesterday's migraine treatment breakthrough, though amidst a complex journey to find a cure, still promises a dramatic impact despite the absence of a 'magic bullet.

84

84

Pharmaceutical Technology

APRIL 12, 2024

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

98

98

Outsourcing Pharma

APRIL 12, 2024

In the fast-paced domain of pharmaceutical contract development and manufacturing organizations (CDMOs), Selkirk Pharma believes it stands out as a beacon of innovation and reliability.

79

79

World Pharma News

APRIL 12, 2024

Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples. The results of the clinical study were published today in Nature Medicine. This combined approach, developed by Florida International University cancer researcher Diana Azzam, was used successfully for the first time to guide treatment of relapsed pediatric cancer patients in collaboration with First Ascent Biomedical and D

Hospitals 82

Hospitals 82

Outsourcing Pharma

APRIL 12, 2024

The European Commission has granted Orphan Medicinal Product designation for zatolmilast an investigational treatment for Fragile X syndrome (FXS), a leading cause of inherited intellectual disability and autism.

76

76

Express Pharma

APRIL 12, 2024

Serum Institute of India (SII) has joined forces with Univercells, a Belgian biotech innovator, to increase accessibility to personalised cancer care. This partnership aims to bring cutting edge treatment options within reach of millions globally. At present, personalised care options such as novel cancer vaccines and specialised immunotherapies are accessible to a few patients only.

Vaccines 76

Vaccines Hospitals 76

BioPharma Dive

APRIL 12, 2024

The decision clears a concern hanging over GLP-1 medicines like Ozempic since reports of suicidal ideation and self-harm among people taking the drugs surfaced in July.

68

68

Express Pharma

APRIL 12, 2024

What is the objective of the 2024: India Healthcare & Life sciences Manifesto? Over the last 10 years, we have been releasing the India Healthcare and Lifesciences Investment Heatmap. 2024 India Healthcare And Lifesciences Investment Heatmap | Kapil Khandelwal KK. These are an annual prediction based on our algos. We see some initial ideas that are not purely in the healthcare and life sciences domain but are going to be impacting the sector.

Online Pharmacies 68

Online Pharmacies Diabetes Communication 68